SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001999371-24-005643
Filing Date
2024-05-03
Accepted
2024-05-03 17:57:02
Documents
2
Group Members
FRED COHENVIDA VENTURES GP III, L.L.C.VIDA VENTURES III, L.P.VIDA VENTURES III-A, L.P.VV MANAGER LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP vida-sc13d_021224.htm SC 13D 142045
2 JOINT FILING AGREEMENT ex1.htm EX-1 11593
  Complete submission text file 0001999371-24-005643.txt   155374
Mailing Address 40 BROAD STREET, SUITE 201 BOSTON MA 02109
Business Address 40 BROAD STREET, SUITE 201 BOSTON MA 02109 (857) 254-9492
Vida Ventures, LLC (Filed by) CIK: 0001724489 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D

Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 5106268331
Kyverna Therapeutics, Inc. (Subject) CIK: 0001994702 (see all company filings)

IRS No.: 831365441 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-94441 | Film No.: 24914777
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)